Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -7.40%82.84B | 19.40%389.08B | 45.90%89.47B | -3.16%325.86B | -13.88%95.93B | -24.11%79.23B | 43.96%89.39B | 4.61%61.32B | 35.06%336.49B | 43.22%111.39B |
| Cost of revenue | -14.39%57.52B | 21.53%289.92B | 64.63%67.19B | -0.75%238.57B | -9.84%71.37B | -19.73%59.79B | 48.62%66.59B | -2.64%40.81B | 20.65%240.38B | 26.90%79.16B |
| Gross profit | 13.66%25.32B | 13.59%99.16B | 8.63%22.28B | -9.17%87.3B | -23.81%24.55B | -35.00%19.44B | 31.89%22.8B | 22.83%20.51B | 92.60%96.11B | 109.35%32.22B |
| Operating expense | -7.60%8.62B | 15.90%37.14B | 22.69%9.33B | -5.81%32.05B | 3.30%9.17B | -22.88%8.07B | -7.60%7.2B | 10.44%7.6B | 13.06%34.02B | 22.77%8.88B |
| Selling and administrative expenses | 9.89%8.37B | 19.15%33.97B | 3.63%7.62B | -8.44%28.51B | -4.25%7.65B | -26.76%7.04B | -4.09%6.47B | 8.26%7.35B | 4.73%31.14B | 10.63%7.99B |
| -General and administrative expense | 9.89%8.37B | 19.15%33.97B | 3.63%7.62B | -8.44%28.51B | -4.25%7.65B | -26.76%7.04B | -4.09%6.47B | 8.26%7.35B | 4.73%31.14B | 10.63%7.99B |
| Other operating expenses | -85.35%251M | -10.29%3.17B | 571.76%1.71B | 22.56%3.54B | 71.53%1.52B | 20.47%1.04B | -30.30%727M | 162.89%255M | 703.62%2.89B | 14,650.00%885M |
| Operating profit | 28.98%16.7B | 12.24%62.01B | 0.35%12.95B | -11.02%55.25B | -34.12%15.38B | -41.52%11.37B | 64.29%15.6B | 31.53%12.9B | 213.41%62.09B | 186.08%23.34B |
| Net non-operating interest income (expenses) | 14.95%123M | -109.40%-154M | -78.43%107M | 40.33%1.64B | -25.36%315M | 16.08%397M | 68.36%431M | 235.14%496M | 226.82%1.17B | 162.11%422M |
| Non-operating interest income | -24.40%533M | 10.02%2.49B | 35.58%705M | 93.09%2.27B | 70.05%721M | 62.97%559M | 80.93%465M | 248.99%520M | 340.98%1.17B | 315.69%424M |
| Non-operating interest expense | -31.44%410M | 322.68%2.65B | 2,391.67%598M | 12,420.00%626M | 20,200.00%406M | 16,100.00%162M | 3,300.00%34M | 2,300.00%24M | -99.58%5M | 103.39%2M |
| Net investment income | -89.67%429M | -76.13%2.8B | -13.84%4.15B | 32.44%11.72B | 180.74%6.37B | 28.53%-3.03B | -11.56%3.57B | -29.05%4.82B | -37.00%8.85B | -66.11%2.27B |
| Gain(Loss) on financial instruments designated as cash flow hedges | 1.78B | 0 | 0 | 6.08B | 0 | |||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -285M | 45.7B | 0 | |||||||
| Income from associates and other participating interests | 399.83%1.77B | -217.76%-252M | -274.26%-589M | -96.99%214M | -447.20%-1.3B | 392.00%246M | 33.91%932M | -94.36%338M | -50.03%7.11B | -92.12%375M |
| Special income (charges) | -200.00%-3M | -5,337.50%-1.31B | 88.89%-1M | 47.83%-24M | 84.21%-3M | 33.33%-8M | 71.43%-4M | -800.00%-9M | 99.40%-46M | -100.05%-19M |
| Less:Restructuring and mergern&acquisition | ---- | --175M | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | 200.00%3M | 650.00%180M | -88.89%1M | -47.83%24M | -84.21%3M | -33.33%8M | -71.43%4M | 800.00%9M | -99.40%46M | 100.05%19M |
| Less:Write off | ---- | --950M | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 590.00%294M | -1,037.50%-182M | 82.35%-60M | 99.26%-16M | 90.08%-115M | 111.53%49M | 188.04%390M | -141.13%-340M | 37.92%-2.17B | -81.95%-1.16B |
| Income before tax | 25.66%20.81B | 57.91%108.61B | -9.07%16.56B | -17.21%68.78B | -18.19%20.64B | -38.98%9.02B | 2.16%20.91B | -19.42%18.21B | 549.08%83.08B | -53.36%25.23B |
| Income tax | 38.10%5.07B | 113.52%25.77B | -15.36%3.67B | -20.10%12.07B | 54.96%2.5B | -89.45%477M | 29.76%4.76B | -18.27%4.34B | 56.46%15.1B | 247.75%1.61B |
| Net income | 22.12%15.74B | 46.08%82.85B | -7.10%12.89B | -16.57%56.72B | -23.18%18.14B | -16.77%8.54B | -3.86%16.16B | -19.77%13.87B | 341.47%67.98B | -57.21%23.62B |
| Net income continuous operations | 22.12%15.74B | 46.07%82.85B | -7.10%12.89B | -16.57%56.72B | -23.18%18.15B | -16.76%8.54B | -3.86%16.16B | -19.78%13.87B | 341.47%67.98B | -57.20%23.62B |
| Noncontrolling interests | -98.21%25M | -44.55%1.69B | 59.61%1.4B | 420.44%3.06B | 305.13%999M | 87.32%-202M | 36.49%1.38B | -47.13%874M | -79.29%587M | -143.21%-487M |
| Net income attributable to the company | 36.73%15.71B | 51.23%81.15B | -11.59%11.49B | -20.38%53.66B | -28.88%17.15B | -26.24%8.75B | -6.45%14.77B | -16.89%13B | 317.48%67.39B | -55.41%24.11B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 36.73%15.71B | 51.23%81.15B | -11.59%11.49B | -20.38%53.66B | -28.88%17.15B | -26.24%8.75B | -6.45%14.77B | -16.89%13B | 317.48%67.39B | -55.41%24.11B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 39.92%61.41 | 58.33%314.91 | -8.46%43.888 | -19.59%198.89 | -27.75%64.104 | -25.71%32.5553 | -6.15%54.4791 | -15.49%47.946 | 326.64%247.33 | -53.10%88.73 |
| Diluted earnings per share | 39.92%61.41 | 58.33%314.91 | -8.46%43.888 | -19.59%198.89 | -27.75%64.104 | -25.45%32.5553 | -6.15%54.4791 | -15.49%47.946 | 326.64%247.33 | -53.10%88.73 |
| Dividend per share | 0 | -8.33%55 | 0 | -18.92%60 | -20.45%35 | 0 | -16.67%25 | 0 | 640.00%74 | 780.00%44 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |